 Intellia Therapeutics, Inc. NASDAQ:NTLA Q3 2022 Results Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Ian Karp - Senior Vice President , Investor Relations and Corporate Communications John Leonard - President and Chief Executive Officer David Lebwohl - Executive Vice President and Chief Medical Officer Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer Glenn Goddard - Executive Vice President and Chief Financial Officer Conference Call Participants Mary Kate Davis - Bank of America Joseph Thome - Cowen and Company Brian Cheng - J.P. Morgan Richard Law - Credit Suisse Swapnil Malekar - Piper Sandler Dae Gon Ha - Stifel Terence Flynn - organ Stanley Maury Raycroft - Jefferies Jay Olson - Oppenheimer Co. Luca Issi - RBC Capital Markets Joon Lee - Truist Securities Operator Good morning. 